We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Equitable Holdings
EQH
$14.2B
| $155M | 0.06% |
6,236,404
+3,103,234
| +99% | +$71.9M |
|
302
Ball Corp
BALL
$16.8B
| $155M | 0.06% |
2,389,485
+156,019
| +7% | +$10.6M |
|
303
Hershey
HSY
$36.8B
| $154M | 0.06% |
1,046,226
-121,183
| -10% | -$18M |
|
304
United Rentals
URI
$72.6B
| $153M | 0.06% |
917,962
-113,860
| -11% | -$16.5M |
|
305
Aflac
AFL
$63.6B
| $152M | 0.06% |
2,865,468
-222,660
| -7% | -$11.8M |
|
306
VICI Properties
VICI
$29.4B
| $151M | 0.06% |
5,909,832
-1,765,142
| -23% | -$42.7M |
|
307
GDS Holdings
GDS
$6.4B
| $151M | 0.06% |
2,921,114
+1,607,208
| +122% | +$72M |
|
308
PENN Entertainment
PENN
$2.71B
| $150M | 0.06% |
5,849,226
-1,142
| -0% | -$25.4K |
|
309
FedEx
FDX
$75.4B
| $149M | 0.06% |
988,606
-59,185
| -6% | -$9.12M |
|
310
Fortinet
FTNT
$117B
| $149M | 0.06% |
6,994,065
+1,298,345
| +23% | +$24.4M |
|
311
KLA
KLAC
$258B
| $149M | 0.06% |
8,364,780
-1,057,220
| -11% | -$17.7M |
|
|
MPT
312
Medical Properties Trust
MPT
$2.82B
| $148M | 0.06% |
7,028,283
+1,044,591
| +17% | +$21.1M |
|
313
Cimpress
CMPR
$2.32B
| $147M | 0.06% |
1,172,690
-75,418
| -6% | -$9.8M |
|
|
XLNX
314
DELISTED
Xilinx Inc
XLNX
| $147M | 0.06% |
1,507,730
-1,135,336
| -43% | -$107M |
|
315
CBRE Group
CBRE
$43.1B
| $147M | 0.06% |
2,400,249
-322,090
| -12% | -$17.8M |
|
316
Zscaler
ZS
$27.2B
| $147M | 0.06% |
3,161,038
-203,242
| -6% | -$9.43M |
|
317
KeyCorp
KEY
$24.4B
| $147M | 0.06% |
7,257,363
-4,241
| -0.1% | -$80K |
|
318
Under Armour
UAA
$2.62B
| $144M | 0.05% |
6,652,742
+3,612,322
| +119% | +$70.1M |
|
319
Xcel Energy
XEL
$48.7B
| $142M | 0.05% |
2,236,384
-9,037
| -0.4% | -$565K |
|
320
ITT
ITT
$19B
| $142M | 0.05% |
1,916,877
-26,848
| -1% | -$1.78M |
|
321
Idexx Laboratories
IDXX
$46.2B
| $141M | 0.05% |
540,486
-13,868
| -3% | -$3.65M |
|
|
SPLK
322
DELISTED
Splunk Inc
SPLK
| $140M | 0.05% |
937,502
+297,398
| +46% | +$39M |
|
323
Corpay
CPAY
$25.8B
| $140M | 0.05% |
487,121
-84,768
| -15% | -$25M |
|
324
T. Rowe Price
TROW
$24.3B
| $139M | 0.05% |
1,137,435
+36,473
| +3% | +$4.31M |
|
325
Labcorp
LH
$25.9B
| $138M | 0.05% |
952,240
-209,254
| -18% | -$30.2M |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.